title: Angiotensin converting enzyme inhibition in diabetic nephropathy. The Collaborative Study Group.
authors.forename: J A
authors.initials: JA
authors.lastname: Breyer
authors.forename: L G
authors.initials: LG
authors.lastname: Hunsicker
authors.forename: R P
authors.initials: RP
authors.lastname: Bain
authors.forename: E J
authors.initials: EJ
authors.lastname: Lewis
mesh_terms: D000293:Adolescent; D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D001794:Blood Pressure; D002216:Captopril / Q000009:adverse effects / Q000627:therapeutic use*; D015331:Cohort Studies; D003404:Creatinine / Q000097:blood; D003928:Diabetic Nephropathies / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D004311:Double-Blind Method; D006801:Humans; D007668:Kidney / Q000503:physiopathology; D016030:Kidney Transplantation; D008875:Middle Aged; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D002216:Captopril; D003404:Creatinine